100
Participants
Start Date
October 31, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
June 30, 2028
Plerixafor
Plerixafor is an antagonist of chemokine receptor-4 (CXCR4) receptor that can release stem cells from the bone marrow niche into the peripheral blood circulation
Gcsf
All patients will receive G-CSF (peg-filgrastim or filgrastim) starting on day -4, prior to planned peripheral blood stem cell collection on day 0.
Thomas Jefferson University
OTHER